Target Details
| UniProt AC | P49841 |
|---|---|
| Gene Symbol | GSK3B |
| Protein Name | Glycogen synthase kinase-3 beta |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) |
Summary
- Multi-target molecules 2,206
- Clinical molecules 168
- Avg pChEMBL 7.19
KEGG Pathways (49)
- Alcoholic liver disease
- Alzheimer disease
- Axon guidance
- B cell receptor signaling pathway
- Basal cell carcinoma
- Breast cancer
- Cadherin signaling
- Cell cycle
- Chemokine signaling pathway
- Colorectal cancer
- Cushing syndrome
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- Gastric cancer
- Growth hormone synthesis, secretion and action
- Hedgehog signaling pathway
- Hepatitis C
- Hepatocellular carcinoma
- Hippo signaling pathway
- Human cytomegalovirus infection
- Human papillomavirus infection
- IL-17 signaling pathway
- IgSF CAM signaling
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- Melanogenesis
- Neurotrophin signaling pathway
- Non-alcoholic fatty liver disease
- PI3K-Akt signaling pathway
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Prion disease
- Prolactin signaling pathway
- Prostate cancer
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Wnt signaling pathway
- Yersinia infection
- mTOR signaling pathway
Active Molecules (2,206)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
YMBIMUZYHSNFFG
|
7.3 | IC50 | 2 | — | |
ZWAPUYGIROZERD
|
7.3 | IC50 | 2 | — | |
DIASEXMEBNQQHZ
|
7.3 | IC50 | 13 | — | |
ISYFANQBAGVSNZ
|
7.3 | IC50 | 2 | — | |
JWEJSOFKTOSBBW
|
7.3 | IC50 | 4 | — | |
LYTFEVSEDITXHS
|
7.3 | Ki | 3 | — | |
NUQDMQZYZIYAFS
|
7.3 | IC50 | 2 | — | |
PEPCSEJJADXCRB
|
7.3 | Ki | 4 | Yes | |
VJTITFHQYIFDAU
|
7.3 | IC50 | 2 | — | |
WEGHHPFXCHFJFR
|
7.3 | Ki | 3 | — | |
IIMMUGRHSXMDBU
|
7.3 | IC50 | 4 | — | |
SRUYEOQJIXGTDT
|
7.3 | IC50 | 3 | — | |
YEYAHVUOLHVSHE
|
7.3 | Ki | 3 | — | |
FUMCKNCUEAQHCV
|
7.3 | Ki | 103 | — | |
GBGNHUZQFPYZRM
|
7.3 | IC50 | 2 | — | |
GZKUIKKDBXPCIY
|
7.3 | IC50 | 13 | Yes | |
IGMVMVBDVWUCTC
|
7.3 | IC50 | 2 | — | |
IXSZNCPQZGGHKB
|
7.3 | IC50 | 2 | — | |
JCFJQIHDZHHMQT
|
7.3 | Ki | 42 | — | |
LOAIUSJMQXSEBK
|
7.3 | IC50 | 2 | — | |
NDGOAYJLMNXBRG
|
7.3 | IC50 | 3 | Yes | |
NFMGZVPRGVERNN
|
7.3 | Ki | 44 | — | |
QLWUDWMYFSWGHK
|
7.3 | Ki | 22 | — | |
RRYFECCPZIZXEK
|
7.3 | IC50 | 2 | — | |
RUTNUZIYAWTMEA
|
7.3 | IC50 | 3 | — | |
UAQJVFADAYIBGC
|
7.3 | Ki | 23 | — | |
UMYBAQLXZPEUQW
|
7.3 | Ki | 15 | — | |
VSZVMUGJWVQEOS
|
7.3 | IC50 | 3 | Yes | |
YJBNTRQKJQHMTM
|
7.3 | Ki | 11 | — | |
ZNTCURDIWRJLBI
|
7.3 | IC50 | 3 | Yes | |
ASLGQVPNOSGBQR
|
7.3 | IC50 | 10 | — | |
CZPAIZKCGQCIOF
|
7.3 | IC50 | 2 | — | |
GWGVEOVRPZFZJP
|
7.3 | Ki | 3 | — | |
HPMITVJMOXAXLV
|
7.3 | Ki | 2 | Yes | |
MFZOHCQCYDYCRY
|
7.3 | Ki | 3 | — | |
ONRSALYRJMUWEV
|
7.3 | IC50 | 2 | — | |
PPRYPAUDEQCBJS
|
7.3 | IC50 | 2 | — | |
WDPWBLOFHHDUCY
|
7.3 | IC50 | 4 | — | |
YBJLQBOUQXKRET
|
7.3 | Ki | 5 | — | |
YRWLBOFEJRBMIO
|
7.3 | Ki | 2 | — | |
ZITKTAJHKVYGTC
|
7.3 | IC50 | 4 | — | |
BHOZITIWJBGALO
|
7.3 | IC50 | 2 | — | |
GYRWNPFZHGOCEC
|
7.3 | IC50 | 2 | — | |
HDRGJVBNKICLJR
|
7.3 | IC50 | 3 | — | |
IYVZGXAXYHRGQR
|
7.3 | IC50 | 2 | — | |
MGXFJFTUXRADSX
|
7.3 | Ki | 3 | — | |
NJIZXSCJRDEYGO
|
7.3 | IC50 | 2 | — | |
RQUYLFVCZMFFCI
|
7.3 | IC50 | 4 | — | |
SUUQWARTYWLJHY
|
7.3 | Ki | 3 | — | |
WWNSPFSYUZCYSP
|
7.3 | Ki | 3 | — |